These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33506699)

  • 1. Synthesis and studies of thiazolidinedione-isatin hybrids as α-glucosidase inhibitors for management of diabetes.
    Kaur R; Kumar R; Dogra N; Kumar A; Yadav AK; Kumar M
    Future Med Chem; 2021 Mar; 13(5):457-485. PubMed ID: 33506699
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
    Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.
    Solangi M; Kanwal ; Mohammed Khan K; Saleem F; Hameed S; Iqbal J; Shafique Z; Qureshi U; Ul-Haq Z; Taha M; Perveen S
    Bioorg Med Chem; 2020 Nov; 28(21):115605. PubMed ID: 33065441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors.
    Xie Z; Wang G; Wang J; Chen M; Peng Y; Li L; Deng B; Chen S; Li W
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28425975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.
    Spasov AA; Babkov DA; Prokhorova TY; Sturova EA; Muleeva DR; Demidov MR; Osipov DV; Osyanin VA; Klimochkin YN
    Chem Biol Drug Des; 2017 Dec; 90(6):1184-1189. PubMed ID: 28585419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V; Gangarapu K; Basavoju S; Tatapudi KK; Katragadda SB
    Bioorg Chem; 2019 Dec; 93():103307. PubMed ID: 31585262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
    Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
    Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isatin based Schiff bases as inhibitors of α-glucosidase: Synthesis, characterization, in vitro evaluation and molecular docking studies.
    Rahim F; Malik F; Ullah H; Wadood A; Khan F; Javid MT; Taha M; Rehman W; Ur Rehman A; Khan KM
    Bioorg Chem; 2015 Jun; 60():42-8. PubMed ID: 25955493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
    Ye GJ; Lan T; Huang ZX; Cheng XN; Cai CY; Ding SM; Xie ML; Wang B
    Eur J Med Chem; 2019 Sep; 177():362-373. PubMed ID: 31158750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
    Dhameja M; Gupta P
    Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
    Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: Synthesis, structure and invitro evaluations.
    Abbasi I; Nadeem H; Saeed A; Kharl HAA; Tahir MN; Naseer MM
    Bioorg Chem; 2021 Nov; 116():105385. PubMed ID: 34600331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.